TSS:Hg 35702.1

Basic information about the TSS

---

TSS ID: hg_35702.1 Species: human Chr: chr3		Start: 23499680 End: 23499699 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000613545.1 Distance: -75 GeneID: 7325 HGNC/MGI_ID: HGNC:12478 UniProt_ID: A0A087X283

Gene_name: ubiquitin conjugating enzyme E2 E2 Gene_symbol: UBE2E2 Gene_synonyms: FLJ25157 UbcH8 Gene_source: HGNC:12478

TATA-Box annotation

---

Distance to TSS:	296363
Nearest PromoterID:	NM_001370228
Entrez ID:	7325
Nearest Unigene:	Hs.475688
Nearest Refseq:	NM_152653
Nearest Ensembl:	ENSG00000182247
Gene Name:	ubiquitin conjugating enzyme E2 E2
Gene Alias:	UBCH8
Gene Description:	ubiquitin conjugating enzyme E2 E2
Gene Type:	protein-coding
CpG%:	0.005
GC%:	0.38806
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@UBE2E2 p2@UBE2E2 p3@UBE2E2 p4@UBE2E2 p5@UBE2E2 p6@UBE2E2
Sample		p1@UBE2E2	p2@UBE2E2	p3@UBE2E2	p4@UBE2E2	p5@UBE2E2	p6@UBE2E2
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	13.05	11.69	3.31	2.34	0.58	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.91	11.94	0.61	2.83	0.20	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	11.77	12.15	0.77	2.51	0.58	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	11.44	7.69	1.04	2.08	0.21	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	8.32	11.47	1.57	3.82	0.67	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.88	8.92	1.16	1.74	0.58	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	11.33	13.94	1.53	1.96	1.53	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	9.93	9.93	0.97	2.18	0.48	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	13.68	13.04	1.28	1.50	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	11.01	23.19	0.00	1.16	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	12.53	14.55	0.40	1.21	1.21	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	11.38	14.64	1.22	1.63	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	15.31	1.93	2.58	1.61	0.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	15.64	2.71	1.95	2.41	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	12.73	1.32	3.29	1.98	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	9.31	1.26	3.52	3.02	0.00	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	11.36	1.97	3.71	1.97	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	8.86	2.11	1.27	2.11	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	9.06	2.13	3.20	2.13	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	13.84	1.20	2.26	1.50	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.70	1.87	2.81	2.67	0.13	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	14.33	2.76	2.76	3.28	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	12.41	2.59	3.36	2.59	0.52	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	12.62	2.43	3.40	2.18	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	12.13	1.55	2.58	3.10	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	1.27	1.27	1.58	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	15.38	2.75	1.65	3.85	0.55	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	16.97	4.72	2.59	2.12	0.71	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	11.15	1.62	2.58	1.94	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	14.66	1.63	2.17	2.17	0.54	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	13.19	1.26	2.72	1.67	0.42	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	13.48	2.74	2.74	1.56	0.39	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	13.93	2.53	2.95	2.95	0.84	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.36	3.46	2.31	2.47	0.66	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	12.15	2.62	3.18	2.99	0.19	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	14.95	2.11	2.87	2.11	0.38	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	13.49	2.66	3.47	2.66	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	13.30	3.22	4.84	2.82	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	13.24	2.43	2.70	1.35	0.27	0.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	13.20	2.40	2.64	2.64	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	10.35	0.94	2.82	2.35	0.71	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	15.66	2.93	3.66	1.90	0.59	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	9.49	2.74	3.16	1.90	0.84	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	14.51	2.45	3.50	1.75	1.05	1.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	14.25	2.21	2.21	4.02	0.40	1.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	9.31	2.56	2.33	1.63	1.16	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	11.52	2.64	2.40	3.36	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	7.15	1.79	2.38	2.09	0.30	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	11.97	3.11	2.87	1.68	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	10.72	1.82	2.43	2.02	1.01	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	11.07	3.89	3.07	2.05	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	12.68	3.34	3.78	2.22	1.56	1.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	13.13	3.19	4.97	1.42	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	11.93	2.98	2.98	2.32	0.66	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	15.94	6.71	7.55	5.03	0.84	4.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	9.64	5.05	3.67	2.76	1.38	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	8.43	4.21	5.51	3.24	0.32	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	7.71	3.85	1.93	2.57	0.32	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.00	5.66	6.60	1.89	1.57	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	12.69	2.12	2.82	3.53	0.71	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	7.85	5.61	5.61	4.49	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	8.76	7.17	3.18	3.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	7.47	2.38	2.72	0.68	1.02	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	12.67	4.87	3.25	0.65	1.62	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	6.74	2.84	4.97	0.35	0.35	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	16.16	0.00	0.00	16.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	31.59	31.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	8.78	4.39	3.41	2.93	2.44	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	11.41	3.47	2.98	4.96	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	12.20	4.22	5.16	1.88	1.41	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	6.95	4.64	3.31	1.99	1.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	12.37	3.71	3.09	2.78	1.86	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	15.29	4.59	3.67	2.14	0.61	0.92
Adipocyte - breast, donor1	11376-118A8	34.37	17.74	7.92	3.33	3.01	0.63
Adipocyte - breast, donor2	11327-117E4	23.10	14.60	6.90	2.73	1.93	1.76
Adipocyte - omental, donor1	11473-119C6	34.99	26.72	6.62	4.58	3.56	0.76
Adipocyte - omental, donor2	11474-119C7	24.67	9.72	3.74	5.23	2.24	1.49
Adipocyte - omental, donor3	11475-119C8	29.14	14.74	4.02	3.35	0.00	0.33
Adipocyte - perirenal, donor1	11476-119C9	33.81	28.71	3.19	2.55	0.64	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	4.40	3.30	1.10	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	19.42	3.61	5.87	3.16	2.71	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	19.64	3.13	4.52	1.74	0.87	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	34.23	8.61	4.89	3.32	0.20	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	18.79	3.35	1.80	3.60	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	23.42	6.97	4.46	3.07	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	21.75	5.88	4.70	5.29	1.76	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	31.77	11.34	6.60	5.71	1.37	0.32
Adipocyte differentiation, day08, donor2	13023-139D8	16.14	7.75	6.46	3.87	0.97	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	12.80	8.53	4.27	2.67	0.00	1.07
Adipocyte differentiation, day08, donor4	13029-139E5	12.24	6.12	2.78	2.78	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	29.53	11.23	9.57	7.90	1.66	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	20.09	6.78	3.77	2.76	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	17.02	8.18	2.95	3.27	1.31	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	14.01	7.61	6.09	3.04	1.83	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	17.68	6.41	3.54	1.33	0.66	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	18.65	5.02	0.00	3.23	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	13.18	1.20	3.59	2.40	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	18.89	5.40	4.86	3.60	1.44	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	18.41	3.35	6.69	1.67	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	22.60	3.70	6.37	2.67	0.41	0.21
Anulus Pulposus Cell, donor1	11248-116E6	21.51	3.78	3.66	1.49	0.34	0.69
Anulus Pulposus Cell, donor2	11463-119B5	16.16	2.20	1.47	4.16	0.00	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	13.93	4.94	5.39	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	12.59	0.87	3.91	3.04	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	6.42	4.28	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	10.76	2.09	2.99	1.20	0.60	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	17.71	2.53	1.26	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	9.24	1.32	1.32	0.00	1.32	1.98
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.50	2.60	4.22	0.97	1.30	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	17.48	2.43	3.88	3.88	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	8.31	1.19	2.97	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	11.30	3.01	5.65	1.88	0.38	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	2.90	5.81	0.73	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	8.78	3.76	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	15.16	1.81	3.62	2.47	0.66	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	15.01	0.00	4.09	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	11.76	2.41	2.71	1.21	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	1.07	4.29	1.07	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	14.36	2.83	6.61	1.13	0.38	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.56	1.60	2.67	1.07	0.53	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	10.73	3.90	5.85	3.90	0.98	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.10	2.49	2.82	1.00	0.33	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	8.41	2.40	3.60	1.20	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	0.00	7.08	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.75	3.09	4.80	0.51	0.86	0.86
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	11.65	0.97	5.83	2.43	0.00	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	15.94	3.79	4.55	1.90	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	10.90	3.63	4.85	2.42	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	9.12	3.99	5.70	1.14	0.57	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	11.54	2.14	3.63	1.28	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	9.29	1.81	3.36	2.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	11.73	3.28	2.82	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	14.79	4.18	2.25	2.25	0.32	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.99	2.14	1.43	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	15.79	2.34	2.92	0.58	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.05	5.72	4.82	2.11	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	9.50	0.00	2.38	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.22	2.54	6.10	2.54	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.23	1.78	4.58	1.53	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	8.26	1.27	4.45	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	0.43	3.02	3.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	12.91	1.91	3.81	1.27	0.85	0.42
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.70	3.19	1.45	0.87	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	12.28	1.89	3.78	1.89	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.56	1.86	3.39	1.19	0.85	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	0.00	4.63	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	14.79	4.23	4.23	2.11	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.86	2.57	2.79	2.14	0.00	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	11.43	4.81	2.41	1.80	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	14.58	4.37	1.46	2.19	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	17.01	3.91	3.45	2.99	0.69	0.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	7.65	2.55	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	13.98	4.07	3.31	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.13	3.92	3.30	2.06	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	15.91	2.75	5.20	0.92	0.61	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.73	1.43	6.21	1.43	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	17.96	3.99	4.21	2.44	0.67	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	6.10	3.05	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	13.29	3.32	2.77	1.66	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	14.30	2.12	3.44	2.12	0.79	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.72	3.63	2.91	1.09	1.45	0.00
Astrocyte - cerebellum, donor1	11500-119F6	20.51	3.32	2.70	1.72	0.12	0.25
Astrocyte - cerebellum, donor2	11580-120F5	16.77	4.45	1.54	2.05	0.17	0.34
Astrocyte - cerebellum, donor3	11661-122F5	20.56	1.26	2.10	2.73	0.21	0.21
Astrocyte - cerebral cortex, donor1	11235-116D2	14.99	1.05	2.44	2.44	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	12.13	1.94	2.59	1.62	0.32	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	16.11	3.28	1.49	1.04	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	39.45	13.30	4.70	4.13	1.83	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	33.32	13.78	7.64	3.88	1.63	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	30.84	12.63	5.12	3.41	2.28	0.34
Basophils, donor1	12241-129G9	17.26	4.97	2.35	1.57	0.52	0.00
Basophils, donor2	12242-129H1	12.99	3.61	2.53	1.44	0.72	0.00
Basophils, donor3	12243-129H2	25.14	3.97	5.88	1.18	1.18	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	32.12	5.17	7.11	3.88	0.22	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	20.57	1.83	2.74	1.83	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	14.35	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	16.32	1.88	3.14	1.88	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	14.56	2.08	2.29	0.62	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	20.27	3.22	3.91	1.15	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	18.89	0.90	4.68	2.16	0.54	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	58.74	24.63	8.14	5.87	0.82	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	54.03	10.71	3.73	4.66	0.00	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	9.91	2.24	1.28	2.56	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	20.68	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	55.79	9.58	11.27	6.20	6.20	0.00
CD14+ Monocytes, donor2	11305-117B9	34.52	15.03	8.54	3.90	10.39	0.19
CD14+ Monocytes, donor3	11381-118B4	36.00	11.42	7.90	3.95	10.10	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	41.04	5.09	8.77	4.81	0.57	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	31.46	3.79	5.31	2.27	0.38	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	41.42	6.25	8.55	4.27	1.31	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	17.49	4.77	4.63	1.59	0.72	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	12.37	3.02	5.43	0.60	0.91	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	19.90	5.45	6.16	0.71	0.95	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	13.56	5.52	4.85	1.51	0.84	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	17.11	6.07	6.07	1.10	1.38	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	22.56	4.96	3.97	2.98	1.24	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.53	2.74	4.11	0.98	1.57	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	19.59	4.99	4.99	1.25	1.60	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	27.86	5.01	5.66	2.18	2.39	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	14.52	3.04	4.45	3.04	3.04	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	29.57	7.92	9.50	5.81	4.22	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	16.64	5.55	5.55	1.11	11.09	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	14.87	3.57	3.27	1.64	1.78	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	16.76	2.79	4.19	2.00	2.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	20.20	4.58	5.20	2.29	1.67	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	14.64	5.49	6.18	0.92	1.37	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.36	6.79	4.30	2.04	2.04	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	14.40	5.24	3.93	0.87	2.18	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	10.76	6.19	4.57	2.15	0.54	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	20.24	3.66	7.33	1.57	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	16.83	6.31	5.05	1.26	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	16.53	4.96	4.41	1.65	3.12	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	32.76	11.27	7.40	2.47	6.69	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	28.52	11.85	7.02	4.39	5.26	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	16.57	3.66	5.75	1.22	0.87	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	23.04	3.35	6.32	0.00	0.37	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	24.57	6.47	4.96	1.72	3.45	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	21.29	5.73	6.55	0.82	1.64	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	32.22	13.44	7.19	4.87	5.10	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	27.61	11.14	3.94	5.57	9.28	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	37.49	10.24	8.72	2.83	0.87	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	37.65	13.63	10.16	2.08	1.85	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	36.39	7.15	9.53	1.30	0.65	0.43
CD14+CD16- Monocytes, donor1	11788-124B6	39.24	9.65	9.19	2.96	1.09	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	37.20	10.48	8.56	2.27	0.87	1.05
CD14+CD16- Monocytes, donor3	11910-125G2	66.22	12.71	11.59	3.79	2.90	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	34.70	8.17	8.93	4.85	1.02	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	39.08	10.10	9.22	1.54	0.66	0.88
CD14-CD16+ Monocytes, donor3	11911-125G3	43.79	10.11	8.00	2.32	0.84	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	54.87	0.00	4.06	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	48.14	4.07	12.20	4.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	46.60	2.07	9.32	5.18	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	47.97	6.93	9.06	12.79	0.00	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	49.32	3.75	11.79	9.65	1.07	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	39.31	4.21	7.72	7.72	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	36.86	7.84	14.12	7.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	35.59	6.59	7.91	7.91	1.32	0.00
CD19+ B Cells, donor1	11544-120B5	60.00	7.40	16.44	12.33	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	40.62	5.80	5.80	4.35	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	33.82	3.03	8.08	9.09	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	0.00	0.00	0.00	0.40	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	3.01	0.00	0.00	2.01	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	12.36	3.93	1.12	3.37	2.81	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	14.28	1.88	0.75	2.63	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	11.50	2.03	0.90	2.71	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	8.93	1.43	0.36	3.57	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	4.90	1.22	0.00	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	3.35	0.91	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	3.06	0.26	0.51	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	2.25	0.00	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	9.77	0.86	0.29	0.00	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	21.33	0.95	0.95	4.27	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.75	0.00	1.40	2.11	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	23.07	0.00	6.59	6.59	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	0.14	0.00	0.00	0.14	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	0.17	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	0.64	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.45	0.00	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.00	0.00	0.00	1.40	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.88	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	4.64	0.84	0.84	2.11	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	3.32	0.62	0.62	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	4.68	0.67	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	25.02	0.54	1.63	5.44	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	23.58	2.14	1.07	4.29	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	26.90	0.00	1.79	5.38	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	0.56	0.00	0.00	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	0.00	0.22	0.00	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	0.42	0.00	0.21	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	2.53	0.51	0.00	1.52	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	1.73	0.43	0.00	1.30	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	1.74	0.44	0.00	0.44	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	6.43	0.99	0.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	4.62	0.00	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	4.19	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	10.52	1.66	1.66	0.83	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	11.04	0.25	0.49	1.23	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	9.24	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	6.80	0.72	1.43	0.72	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1.38	0.00	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	4.91	0.33	0.00	0.00	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	0.75	0.38	0.38	1.13	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	12.88	0.25	0.25	1.77	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	7.57	2.29	0.00	2.52	0.92	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	3.83	2.16	0.48	1.92	0.24	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	6.84	1.92	0.00	2.19	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	6.30	3.90	0.90	1.80	2.40	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	8.16	3.36	0.48	2.16	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	5.68	3.18	1.59	0.91	0.23	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	3.91	1.30	2.17	1.74	1.96	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	3.42	1.58	0.79	1.58	0.79	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	5.86	1.17	0.94	2.35	0.94	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	7.85	3.32	1.81	1.81	1.51	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	6.39	2.32	1.74	1.45	2.03	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	7.99	4.26	2.13	2.40	1.07	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	3.94	3.50	3.06	0.88	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	6.83	2.73	1.37	1.82	0.46	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	5.97	3.73	2.98	0.75	1.49	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	7.20	1.80	1.08	0.72	1.08	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	6.04	1.15	0.58	2.88	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	6.84	1.89	0.71	0.71	1.65	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	7.61	3.17	0.63	2.22	0.63	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	6.46	3.08	1.54	2.46	1.85	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	8.01	3.21	2.24	2.56	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	6.88	2.68	1.15	0.38	0.38	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	9.06	1.97	0.79	1.18	1.58	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	5.29	0.76	1.51	2.27	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	18.47	5.62	1.61	4.01	4.01	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	24.48	4.90	2.10	2.10	4.90	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	11.02	1.00	4.01	3.01	3.01	0.00
Cardiac Myocyte, donor1	11525-119I4	27.42	10.97	9.14	9.14	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	9.88	1.98	1.48	2.96	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	30.10	5.58	4.10	2.53	0.63	0.21
Chondrocyte - de diff, donor1	11261-116G1	18.72	2.08	2.08	2.08	0.35	0.00
Chondrocyte - de diff, donor2	11338-117F6	15.28	3.55	1.78	2.49	0.71	0.00
Chondrocyte - de diff, donor3	11410-118E6	20.59	5.01	4.10	2.73	0.68	0.68
Chondrocyte - re diff, donor2	11339-117F7	19.70	2.69	7.16	0.90	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	18.20	2.43	3.64	0.40	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	23.53	2.64	3.44	2.87	0.23	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	16.03	3.63	3.63	2.99	0.43	0.21
Ciliary Epithelial Cells, donor3	11399-118D4	19.29	1.50	3.10	2.21	0.09	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	54.10	11.65	11.55	5.04	1.93	0.28
Corneal Epithelial Cells, donor1	11526-119I5	50.06	5.49	6.81	3.29	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	31.85	6.83	12.51	2.28	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	34.00	4.86	7.16	3.58	0.77	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	30.05	9.74	10.73	2.81	1.82	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	36.27	7.25	9.78	4.10	1.26	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	37.96	24.15	10.35	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	25.05	8.86	9.18	2.16	1.51	0.43
Dendritic Cells - plasmacytoid, donor1	11228-116C4	85.41	7.52	3.76	9.22	1.37	0.34
Dendritic Cells - plasmacytoid, donor2	11309-117C4	75.08	7.83	5.88	8.49	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	93.89	10.65	4.84	8.71	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	14.18	3.34	2.33	1.50	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	8.80	0.59	0.59	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	13.57	2.26	2.26	1.98	0.57	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	10.22	1.57	3.93	0.79	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	12.51	1.45	3.78	1.45	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	19.29	1.88	4.24	0.47	0.47	0.47
Endothelial Cells - Artery, donor3	11413-118E9	15.78	2.63	3.33	1.05	0.53	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	19.95	4.43	3.10	2.66	0.44	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	26.47	3.04	4.87	0.61	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	23.40	4.51	5.36	3.10	0.28	0.28
Endothelial Cells - Microvascular, donor1	11265-116G5	20.21	2.08	2.08	0.89	1.19	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	15.10	3.12	4.69	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	15.17	3.54	1.99	0.85	0.14	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	20.81	6.40	4.80	0.80	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	14.15	3.67	2.62	1.57	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	22.99	3.85	3.85	3.60	0.25	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.08	2.61	2.82	3.26	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	17.83	3.18	4.15	2.32	0.24	0.00
Endothelial Cells - Vein, donor1	11267-116G7	10.24	1.14	2.28	1.14	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	9.08	5.59	0.00	2.79	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	17.27	3.14	2.67	1.57	0.16	0.16
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	3.30	1.65	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	0.00	0.00	0.00	3.57	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	21.01	1.95	4.64	1.95	0.24	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	33.28	2.08	12.48	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	32.84	16.83	8.62	2.46	0.82	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	13.14	3.50	4.93	1.20	0.22	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	17.77	4.23	2.82	1.63	0.54	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	20.50	5.94	4.37	1.58	0.73	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	35.62	6.96	8.60	2.32	0.96	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	27.42	5.91	5.91	2.53	0.21	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.03	3.69	3.69	2.90	0.26	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	20.26	2.66	4.32	2.33	0.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	17.69	5.90	6.35	3.63	0.91	0.00
Fibroblast - Cardiac, donor2	11345-117G4	15.16	3.79	2.27	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	12.46	3.15	3.15	0.47	0.79	0.16
Fibroblast - Cardiac, donor4	11452-119A3	26.98	3.64	6.37	3.64	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	18.65	3.55	1.90	1.14	0.51	0.38
Fibroblast - Cardiac, donor6	11460-119B2	17.13	3.34	2.12	0.91	0.45	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	22.38	2.28	2.81	2.81	0.00	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.12	1.29	4.31	2.16	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	10.25	4.39	4.39	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	48.20	4.84	5.07	2.08	0.23	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	20.52	0.85	2.04	2.04	0.17	0.00
Fibroblast - Dermal, donor1	11269-116G9	22.07	3.99	4.93	1.64	2.11	0.23
Fibroblast - Dermal, donor2	11346-117G5	19.34	2.83	2.83	1.42	1.42	0.00
Fibroblast - Dermal, donor3	11418-118F5	21.88	3.99	7.13	2.66	2.18	0.00
Fibroblast - Dermal, donor4	11450-119A1	20.46	3.50	1.81	1.36	0.45	0.23
Fibroblast - Dermal, donor5	11454-119A5	22.50	5.41	3.49	1.05	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	21.28	5.20	3.25	2.27	0.65	0.00
Fibroblast - Gingival, donor1	11237-116D4	24.36	3.54	8.33	1.67	0.62	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	20.44	4.19	5.76	1.83	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	20.29	2.64	3.03	0.92	0.00	0.00
Fibroblast - Gingival, donor3	11394-118C8	26.11	1.93	5.12	1.64	0.48	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	27.01	2.08	2.08	2.08	1.04	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	18.50	5.99	3.88	2.29	0.00	0.53
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.16	2.18	2.65	1.87	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	12.98	4.60	2.84	1.49	0.27	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	16.23	5.65	3.18	0.35	1.41	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	18.13	5.26	2.05	1.17	0.44	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	12.14	3.14	3.82	1.09	0.41	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	14.37	4.39	3.40	1.32	0.22	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.95	4.55	4.84	2.05	0.29	0.44
Fibroblast - Lung, donor1	11270-116H1	12.23	0.00	6.80	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	22.38	1.49	2.98	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	27.01	3.80	6.12	2.11	1.06	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	33.32	10.00	8.33	3.33	2.50	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	20.98	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	12.31	2.80	3.64	2.52	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	27.20	5.28	10.15	6.09	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	11.98	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96	5.96	11.91	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	23.47	3.69	3.49	1.36	0.78	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	24.27	6.07	2.73	2.43	0.15	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.62	2.45	4.28	1.53	1.22	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	19.46	2.29	4.58	0.38	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	15.66	4.59	4.59	2.16	0.81	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	20.76	7.42	3.48	1.86	0.23	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	17.57	3.09	2.76	1.11	0.44	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	17.88	3.45	4.27	1.02	0.61	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	22.05	4.68	0.67	0.67	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	19.77	1.58	3.16	0.79	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	7.94	1.59	0.99	0.40	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	17.94	3.73	2.13	1.78	0.89	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.57	2.96	4.53	2.76	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	6.02	2.11	1.20	0.60	0.00	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	14.25	2.70	3.45	1.19	0.11	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.63	2.28	0.76	0.51	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	13.13	3.94	1.97	1.31	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	12.63	3.01	4.21	2.01	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	15.27	3.92	2.81	1.81	0.40	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	18.44	3.63	3.32	1.51	0.30	0.60
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.07	3.65	3.48	2.07	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	34.02	4.79	3.93	4.79	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	6.90	2.96	1.64	0.00	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	12.36	1.81	2.34	0.85	0.21	0.32
Fibroblast - skin walker warburg, donor1	11554-120C6	14.84	2.87	2.19	1.69	0.67	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	5.18	1.57	2.20	0.78	0.31	0.47
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	22.66	6.97	13.07	3.49	2.61	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	22.54	3.64	5.55	2.25	0.17	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	23.68	3.90	4.42	0.78	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	22.74	4.09	4.85	1.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.08	6.89	0.77	2.30	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	9.57	0.64	0.64	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	36.80	17.12	0.57	2.00	0.00	0.86
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	49.36	16.82	2.21	3.31	0.00	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	29.00	8.90	2.05	1.83	0.23	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	31.30	11.29	0.40	1.19	0.00	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	43.09	14.54	0.79	1.06	0.26	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	31.64	16.96	1.63	1.30	0.33	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	29.19	15.04	0.00	0.88	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	33.21	8.90	0.57	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	32.02	8.74	0.74	2.96	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	25.25	10.21	0.54	1.34	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	37.91	7.19	1.36	1.73	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	40.70	9.41	0.42	2.91	0.14	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	21.75	8.34	0.20	2.03	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	19.62	7.07	3.19	3.19	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	29.65	7.97	1.99	3.61	0.37	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	22.51	6.78	1.31	2.40	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	23.93	7.39	0.89	2.95	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	31.47	10.33	2.07	3.50	0.16	0.48
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	23.46	6.70	1.56	2.90	0.89	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	20.77	6.05	1.61	2.62	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	27.65	9.84	2.88	2.54	0.34	0.85
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	23.94	9.22	1.60	3.99	0.53	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.70	7.39	1.77	3.33	0.62	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.98	5.64	1.71	3.93	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.88	7.86	1.44	2.88	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.88	7.65	2.16	2.25	0.17	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	22.66	7.96	2.04	2.04	0.00	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	20.22	5.98	1.24	3.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	34.36	7.26	1.96	3.34	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	17.34	5.67	0.83	2.50	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	20.50	4.41	0.44	2.20	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	28.90	3.69	1.72	3.07	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	14.43	4.21	1.30	1.95	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	22.13	2.57	2.25	1.92	0.64	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	25.77	4.93	1.71	2.65	0.09	0.09
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	15.50	3.01	1.27	1.11	0.00	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	17.03	3.04	0.91	0.91	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	19.34	4.70	2.09	1.46	0.10	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	12.51	2.20	1.76	1.54	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	19.36	2.52	1.12	2.81	0.84	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.48	2.50	2.50	1.02	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	8.29	3.21	2.14	0.27	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	9.33	3.21	0.92	0.61	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	14.25	2.59	1.81	0.91	0.00	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	12.20	2.98	2.44	0.81	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	16.59	3.50	2.58	2.58	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	19.96	5.92	2.85	2.63	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	19.83	0.99	1.98	1.98	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	18.34	5.41	3.03	2.11	0.53	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	19.37	3.83	4.64	1.41	0.61	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	39.39	5.85	3.05	5.34	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	39.02	16.52	0.60	2.19	0.00	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	40.21	7.86	0.77	2.47	0.00	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	39.28	15.14	1.02	2.25	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	20.65	12.52	0.63	2.50	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	24.30	9.32	0.85	1.41	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	38.28	13.37	1.38	1.38	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	12.37	7.42	0.00	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	16.63	13.93	0.39	1.16	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	16.04	22.46	0.00	4.81	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	29.56	13.91	3.48	3.48	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	15.30	9.76	0.00	0.65	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.77	11.12	0.82	0.41	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	13.33	6.66	3.33	3.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	21.53	7.83	1.40	2.52	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	23.86	9.81	0.65	2.61	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	19.29	7.55	0.00	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	22.58	11.13	1.27	1.59	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	13.59	9.85	0.34	3.06	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	25.06	4.18	0.00	4.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	34.36	9.74	0.57	2.86	0.00	1.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	20.42	7.10	0.30	1.78	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	25.41	6.78	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	23.20	11.18	0.83	1.24	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	18.41	9.90	1.38	2.76	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	21.07	10.54	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.52	13.45	2.69	1.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	26.08	10.43	2.61	3.26	0.00	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	28.09	8.69	1.34	1.34	0.00	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	47.39	9.63	1.54	3.47	0.39	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	36.63	7.87	4.45	4.11	0.00	1.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	59.63	14.91	2.48	4.97	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	36.80	9.44	1.42	3.30	0.47	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	46.47	7.85	0.60	4.22	0.00	1.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	36.62	8.65	3.05	2.54	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	41.08	10.77	1.60	2.79	0.00	1.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	65.12	10.85	0.49	5.43	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	50.76	5.90	1.18	5.90	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	51.34	9.92	0.00	5.25	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	53.10	8.78	0.44	3.95	0.00	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	36.45	5.93	3.39	2.54	0.00	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	24.47	4.18	3.58	3.58	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	15.53	7.28	1.46	4.85	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	9.13	4.57	4.57	1.14	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	17.88	4.16	7.90	1.25	0.83	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	10.12	0.00	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.88	1.90	1.59	0.95	0.32	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	10.86	2.09	2.51	0.42	1.25	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.07	2.79	2.67	1.97	0.58	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	15.53	4.05	3.21	2.19	0.00	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.29	2.96	2.50	0.23	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	13.66	3.28	1.42	1.97	0.44	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	12.04	2.15	2.15	1.93	0.21	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	13.35	2.37	2.58	2.37	0.22	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.96	4.23	3.11	1.00	0.00	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	9.61	2.74	2.23	1.54	0.34	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	8.65	1.60	1.60	0.96	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	11.75	3.36	2.24	2.24	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	19.04	4.33	3.03	2.16	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	13.22	0.00	2.64	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	27.51	4.59	2.47	3.17	1.06	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	22.52	3.63	5.09	2.91	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	11.89	2.27	1.22	0.70	0.00	0.17
Hepatocyte, donor1	11523-119I2	10.90	8.47	10.90	2.42	1.21	0.00
Hepatocyte, donor2	11603-120I1	8.62	5.39	10.77	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	24.54	8.59	6.14	1.23	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	102.47	35.90	3.26	7.83	0.00	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	11.01	2.80	0.87	1.75	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	17.56	3.16	3.43	0.82	0.14	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	1.38	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	3.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	5.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	3.15	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	0.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	1.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	1.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	1.26	0.00	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	14.37	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.92	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	0.94	0.00	0.00	0.47	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	2.72	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	2.15	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.64	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	0.31	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	0.70	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	1.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	2.13	0.00	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	0.00	0.00	0.00	1.39	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	1.84	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	25.13	5.22	4.90	1.63	0.41	0.57
Keratinocyte - epidermal, donor2	11349-117G8	15.23	1.17	3.51	1.17	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	22.72	2.56	3.69	1.70	0.28	0.09
Keratinocyte - oral, donor1	11251-116E9	35.42	1.93	4.77	2.84	0.34	0.00
Keratocytes, donor1	11527-119I6	53.29	5.16	5.16	3.09	0.00	0.69
Keratocytes, donor2	11607-120I5	16.41	1.17	5.86	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	19.36	3.56	1.78	0.79	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	0.00	0.00	2.20	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	11.87	1.08	3.24	6.47	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	21.91	3.23	2.54	2.42	0.23	0.12
Lens Epithelial Cells, donor3	11690-122I7	27.14	4.34	5.55	3.23	1.11	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	17.31	7.00	2.61	1.19	0.71	0.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	13.40	6.98	1.95	1.95	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	16.84	6.45	4.09	1.26	0.31	0.94
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	15.06	4.84	5.38	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	11.98	6.30	2.21	2.21	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	12.51	5.50	2.80	1.08	0.86	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	13.54	8.21	3.28	2.05	0.82	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	15.17	5.31	3.03	0.76	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	13.37	7.60	2.11	0.84	0.56	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	20.17	5.93	1.98	1.98	0.40	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	17.06	5.23	2.33	1.16	0.78	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	9.81	5.55	2.59	0.19	0.93	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	15.68	6.62	4.88	0.35	0.35	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	18.84	5.01	3.34	0.48	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	15.93	5.77	2.33	1.24	0.69	0.41
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	19.71	8.93	2.77	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	14.96	4.68	1.87	1.56	0.94	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	15.55	7.32	2.56	1.83	1.10	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	21.39	4.61	1.97	0.66	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	12.30	5.27	2.05	0.59	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	11.95	5.48	2.99	0.50	1.49	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	14.55	4.85	2.42	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	19.66	7.27	2.69	1.08	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	14.84	6.81	4.39	1.21	0.76	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	14.00	5.18	3.63	1.04	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	21.15	6.70	2.51	0.42	0.42	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	14.44	4.21	4.21	0.90	1.20	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	19.26	7.57	1.38	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	19.19	6.96	3.01	0.75	0.75	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	13.15	4.67	2.44	1.17	0.64	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	13.57	11.15	1.94	1.94	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	18.52	8.60	0.66	2.65	0.66	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	11.77	5.70	1.86	0.50	0.50	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	23.32	5.92	2.59	1.85	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	16.31	8.65	1.48	0.49	0.00	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	14.16	4.95	1.79	0.69	0.69	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	15.76	4.82	5.47	2.25	1.29	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	21.91	11.87	1.52	1.83	1.52	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	16.38	5.18	3.64	1.12	0.56	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	17.42	10.31	2.84	0.36	0.71	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	12.60	8.73	1.94	0.48	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	10.27	5.76	2.18	1.09	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	21.13	5.37	2.51	2.51	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	17.97	6.53	1.31	1.31	0.65	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	10.59	2.12	2.59	1.41	1.18	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	18.69	5.82	3.59	1.73	0.87	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	15.37	6.66	2.82	0.51	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	11.93	4.48	1.79	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	6.80	4.53	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	7.67	1.53	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.97	1.48	0.74	4.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	3.81	1.27	0.85	0.42	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	6.33	2.11	2.11	1.41	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	5.60	1.87	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	6.70	3.09	3.09	1.55	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	1.19	1.19	0.00	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	5.43	2.04	1.13	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.40	2.62	1.16	0.87	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.20	1.80	0.45	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.54	2.85	1.35	0.68	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.19	3.59	1.54	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	8.12	2.82	0.71	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	6.00	2.00	2.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	5.60	1.53	3.06	2.04	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	7.20	0.80	1.87	0.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	8.31	2.27	1.51	0.76	0.00	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	6.14	3.68	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	9.79	0.00	2.45	1.63	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	8.75	2.08	2.29	1.04	0.00	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	3.08	2.52	1.12	1.12	0.00	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	7.21	0.00	0.00	1.03	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	7.26	1.74	1.16	1.74	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	6.28	2.09	1.79	0.60	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	8.85	3.32	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	10.25	2.12	2.83	0.35	0.35	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.79	1.11	1.48	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	5.76	2.30	2.30	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	6.91	2.69	1.15	1.15	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	2.83	1.70	0.57	2.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	5.74	0.82	2.46	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.78	1.36	0.90	0.45	0.45	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	6.46	0.72	0.72	1.44	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	6.72	2.99	0.00	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	7.43	1.86	2.23	1.49	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	4.31	3.02	1.29	1.72	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.14	1.71	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	7.33	0.67	1.00	1.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	3.62	1.81	1.21	1.21	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	7.11	2.84	0.71	0.71	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	4.47	1.03	2.75	1.72	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.44	1.61	1.61	1.07	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	5.39	2.02	2.02	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	6.67	1.11	1.48	1.11	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	6.98	1.16	0.00	1.16	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	0.00	1.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	4.40	0.80	2.00	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	4.36	5.09	0.73	0.73	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	9.96	2.30	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	4.44	2.96	1.48	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	5.65	2.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.53	1.01	2.51	3.02	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	8.56	0.00	0.90	2.25	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	5.16	0.00	1.72	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.23	1.78	2.23	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	7.82	2.74	1.17	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	9.24	1.98	0.00	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	7.78	1.04	1.04	2.08	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	8.75	1.75	0.88	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.71	1.12	0.56	0.00	0.00	1.12
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.39	2.65	0.88	1.32	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.94	3.47	0.39	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	5.06	2.53	0.51	1.01	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	9.13	1.92	2.40	0.48	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	6.36	1.59	2.39	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	6.08	2.43	1.22	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	6.92	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	8.36	2.28	2.28	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	9.30	3.10	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	6.65	1.81	1.21	1.21	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	7.29	2.54	2.22	1.58	0.32	0.95
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.26	2.13	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	8.05	2.87	2.30	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	11.31	2.06	0.51	1.54	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	6.37	1.41	2.83	0.71	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	6.81	1.70	3.97	1.13	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	10.40	2.50	1.25	1.25	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	8.61	2.35	1.57	0.78	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	7.52	1.25	2.09	0.84	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.04	2.79	1.86	1.86	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.02	4.01	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	11.76	1.07	2.14	1.07	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.34	2.02	1.62	1.62	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	3.67	3.67	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	7.11	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	8.55	1.14	1.71	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	4.60	0.77	3.07	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	3.28	2.19	2.19	1.09	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	2.23	4.45	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	9.88	2.86	1.04	1.56	0.26	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	7.29	1.99	1.33	2.65	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	20.79	4.16	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	33.50	4.79	5.01	3.65	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	29.91	9.73	6.97	3.67	1.84	0.00
Macrophage - monocyte derived, donor3	11389-118C3	23.99	5.51	8.00	2.75	0.92	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	16.46	3.19	4.78	2.66	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	26.94	6.02	5.55	1.90	0.48	0.48
Mallassez-derived cells, donor3	11930-125I4	24.18	3.61	6.25	1.81	0.28	0.00
Mammary Epithelial Cell, donor1	11273-116H4	38.46	10.46	7.27	2.29	1.59	0.60
Mammary Epithelial Cell, donor2	11350-117G9	26.06	6.37	4.34	0.87	0.58	0.29
Mammary Epithelial Cell, donor3	11422-118F9	16.21	2.74	2.99	1.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	18.98	6.78	6.78	2.71	4.07	0.00
Mast cell, donor1	11563-120D6	6.81	0.97	1.51	1.30	0.22	0.00
Mast cell, donor2	11565-120D8	2.97	0.30	0.59	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	3.15	0.45	0.45	0.90	0.00	0.23
Mast cell, donor4	11567-120E1	0.89	0.00	0.18	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	2.77	0.33	1.11	0.11	0.22	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	4.67	0.58	3.50	0.00	1.75	0.00
Mast cell, expanded, donor5	11939-126A4	4.24	0.11	0.57	0.23	0.11	0.11
Mast cell, expanded, donor8	11941-126A6	1.17	0.17	0.17	0.33	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	15.82	3.68	2.98	1.79	0.30	0.10
Melanocyte - dark, donor2	11582-120F7	7.96	2.42	3.46	2.42	0.00	0.35
Melanocyte - dark, donor3	11663-122F7	9.27	0.80	2.03	0.94	0.07	0.00
Melanocyte - light, donor1	11274-116H5	6.11	0.71	1.65	1.41	0.00	0.00
Melanocyte - light, donor2	11351-117H1	6.82	0.68	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	5.20	0.87	0.00	1.73	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	13.12	0.94	2.08	0.73	0.00	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	2.15	0.27	0.54	0.54	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	11.52	0.54	1.87	1.34	0.27	0.00
Meningeal Cells, donor1	11493-119E8	31.88	7.07	3.23	2.98	0.74	0.12
Meningeal Cells, donor2	11573-120E7	27.73	4.84	2.64	1.32	0.00	0.00
Meningeal Cells, donor3	11654-122E7	15.16	4.32	1.55	2.45	1.06	0.24
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	16.82	2.00	1.43	1.43	0.29	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	19.02	3.32	4.93	3.12	1.11	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	18.40	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	2.62	2.62	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.25	4.31	1.44	2.87	0.00	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	15.67	2.33	3.60	1.48	0.21	0.42
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	9.05	2.51	1.01	1.51	1.01	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	18.24	1.76	1.54	3.30	0.88	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	11.69	4.38	2.19	0.73	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	15.14	2.46	1.64	0.61	0.61	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.47	1.11	2.77	2.08	0.14	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	10.41	1.12	2.23	2.23	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	12.50	1.97	1.18	1.84	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.57	2.67	2.37	2.67	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	2.34	0.00	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	11.53	2.56	0.64	0.64	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	25.52	4.61	3.19	2.13	1.42	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	18.14	1.25	1.25	1.88	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	5.81	1.45	0.73	2.18	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	21.21	2.65	6.36	1.06	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	27.03	5.00	3.50	3.00	0.50	0.50
Mesothelial Cells, donor3	11402-118D7	19.15	1.59	5.71	2.60	0.14	0.29
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	35.11	8.10	4.05	5.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	31.77	9.85	13.30	4.19	1.23	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	21.50	9.42	12.37	2.94	1.18	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	10.37	0.00	10.37	6.91	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	21.70	4.34	4.65	0.93	0.62	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	20.95	3.94	6.22	1.45	1.45	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	16.21	0.00	16.21	11.58	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	24.28	5.76	10.01	3.50	1.00	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	25.14	6.52	10.24	4.19	4.65	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	24.79	6.50	10.36	1.63	1.63	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	27.32	8.32	9.90	4.36	2.38	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	8.55	8.55	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	20.35	3.54	7.08	7.08	1.77	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	20.52	6.84	9.50	2.28	2.66	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	22.37	14.47	9.21	3.95	1.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	18.89	6.37	4.46	2.55	1.91	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	9.21	6.45	3.68	7.37	2.76	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	15.50	5.07	10.43	2.09	1.19	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	5.03	6.71	8.38	3.35	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	18.32	9.03	7.78	2.26	1.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	17.11	8.56	6.65	2.38	2.85	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	17.69	8.85	6.08	7.74	6.08	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	17.50	8.06	6.91	3.91	2.76	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	18.93	7.99	7.36	3.58	3.37	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	15.90	7.34	3.26	1.83	3.67	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	20.60	7.08	5.79	3.00	2.36	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	17.34	8.22	7.34	2.00	3.78	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	13.36	5.48	4.38	4.60	3.50	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	21.80	8.11	6.59	4.56	5.07	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	18.23	14.91	6.63	4.97	6.63	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.03	9.78	3.53	4.08	2.45	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	20.29	9.41	5.00	2.65	4.12	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	10.90	1.09	4.36	3.27	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	16.82	11.53	4.32	3.36	4.81	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	19.21	8.81	5.60	2.40	4.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	15.08	2.74	16.45	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.02	9.51	4.00	4.00	3.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	22.42	2.04	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.52	14.01	4.82	4.38	2.19	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	37.52	11.04	3.31	3.31	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	17.29	12.17	5.12	5.12	1.92	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	16.36	15.62	5.21	4.71	3.72	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	26.44	11.13	6.26	6.96	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	13.26	6.63	11.05	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	22.22	8.55	4.10	5.13	3.42	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	23.19	10.07	6.13	1.31	3.06	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	28.41	9.23	6.75	4.26	3.55	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.77	15.15	5.61	2.81	3.93	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	23.69	15.38	5.82	2.49	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	24.48	7.58	6.41	3.50	2.33	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	24.43	10.26	5.13	3.32	1.81	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	26.30	6.68	4.17	2.09	5.84	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	14.44	0.00	14.44	14.44	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	12.93	1.85	6.46	2.77	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	25.04	17.64	5.12	2.28	1.71	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	25.01	8.01	6.22	2.35	1.93	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	22.81	12.44	3.89	3.37	3.11	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	27.45	19.30	4.29	2.57	3.43	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	18.42	8.26	3.81	3.81	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.82	11.48	5.07	2.40	2.67	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	28.74	10.48	8.68	4.79	3.89	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	22.60	5.79	4.38	1.98	0.99	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.66	8.92	5.73	4.78	3.82	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	26.98	16.36	7.74	2.43	2.21	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	23.51	13.27	6.45	3.03	1.52	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.85	13.92	5.11	2.56	3.41	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	27.53	12.29	7.37	3.44	3.69	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	26.72	8.47	2.61	4.56	0.65	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	23.82	7.35	5.88	2.06	1.76	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	26.81	13.55	6.63	2.59	2.59	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	22.67	9.07	5.36	0.82	2.06	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	26.80	8.93	5.06	2.68	1.79	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	0.00	3.77	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	8.91	7.13	5.35	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	21.03	4.93	8.54	1.97	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	19.99	6.31	4.21	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	23.92	4.74	5.14	1.38	0.59	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	29.80	10.24	8.38	1.86	0.93	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	27.79	4.88	7.14	5.26	0.38	0.75
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	20.51	7.19	9.06	1.33	0.00	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	18.55	1.92	5.09	1.70	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	12.52	6.63	9.58	1.47	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	20.15	5.50	9.16	2.20	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	10.89	3.11	12.44	3.11	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	24.58	4.81	5.34	7.48	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	11.59	3.86	7.73	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	17.17	3.03	4.04	2.02	1.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	23.19	7.59	10.12	3.37	1.69	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	8.17	4.09	1.36	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	17.80	7.63	9.54	5.09	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	30.77	3.24	7.29	2.43	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	21.15	3.02	13.59	3.02	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	45.68	22.84	5.71	5.71	5.71	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	0.00	13.05	9.79	3.26	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	28.51	4.75	0.00	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	26.93	8.83	6.46	2.37	1.51	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	26.65	3.14	7.32	1.57	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	6.67	3.34	6.01	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.85	3.76	7.93	0.83	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	11.79	3.99	3.04	1.33	0.38	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	25.53	6.38	14.36	4.79	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	6.12	0.00	4.08	3.40	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	12.86	1.84	9.19	1.84	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	7.95	1.26	3.35	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.35	2.79	3.02	1.16	0.23	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	1.62	4.32	1.35	0.00	0.27
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	15.77	4.41	2.73	1.26	0.42	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	7.94	0.99	4.47	2.48	0.00	0.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.85	1.62	2.71	1.35	0.00	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	9.29	1.36	2.49	0.91	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	12.25	2.78	4.57	1.47	0.00	0.33
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	21.14	5.65	6.93	2.00	0.18	0.91
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	10.61	3.71	1.06	2.65	0.53	1.59
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	10.21	1.20	1.80	2.40	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	14.77	4.59	3.28	1.31	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.81	2.76	4.07	1.14	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	20.81	6.17	5.12	3.17	1.06	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	2.81	1.41	1.41	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	8.73	1.84	1.38	0.00	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	11.57	1.29	6.11	1.29	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	20.69	4.83	5.17	1.72	0.69	2.07
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	20.23	27.81	2.53	2.53	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	19.38	4.68	3.79	1.56	0.45	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.08	2.12	1.69	3.39	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	9.97	3.32	3.09	2.85	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.87	1.72	6.01	2.15	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	54.17	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	12.00	3.00	2.00	3.00	0.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	21.19	4.51	5.86	1.35	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.35	4.76	3.57	2.78	0.40	0.79
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	14.86	0.93	2.79	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	15.51	6.05	4.54	1.51	0.00	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	10.10	3.26	3.58	0.98	0.65	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	17.43	2.18	6.97	3.92	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	22.16	10.40	7.24	4.07	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	3.53	1.76	3.53	3.53	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	1.99	2.66	1.33	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	17.36	3.47	4.46	3.47	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	11.48	5.36	6.89	1.91	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	19.05	2.12	5.14	1.81	0.30	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	22.99	8.84	5.75	1.99	0.44	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	8.81	4.07	11.52	1.36	0.00	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	0.00	5.11	15.33	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	16.46	5.49	5.49	2.44	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.13	4.41	7.24	2.83	0.63	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.01	4.84	5.45	3.03	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.12	3.96	5.54	0.79	1.58	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	12.47	10.20	1.13	2.27	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	10.12	0.00	0.00	0.00	5.06
Myoblast, donor1	11241-116D8	17.89	6.34	4.84	1.37	1.12	0.25
Myoblast, donor2	11322-117D8	14.19	4.99	3.45	1.53	0.96	0.38
Myoblast, donor3	11398-118D3	14.63	3.03	2.86	2.19	1.85	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.29	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	5.23	0.92	0.31	0.62	0.62	0.00
Natural Killer Cells, donor2	11311-117C6	1.81	0.30	0.00	0.60	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	5.89	0.74	0.92	1.10	0.92	0.18
Neural stem cells, donor1	11275-116H6	12.70	2.90	3.27	1.09	0.36	0.00
Neural stem cells, donor2	11352-117H2	19.26	1.93	3.85	0.00	0.00	0.00
Neurons, donor1	11494-119E9	11.38	1.14	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	9.91	1.98	0.88	0.88	0.00	0.00
Neurons, donor3	11655-122E8	1.64	4.93	4.11	0.82	0.00	0.00
Neutrophils, donor1	11233-116C9	0.93	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	1.22	0.61	0.00	0.61	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	23.75	2.73	2.37	2.73	0.24	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	18.56	3.58	4.56	2.93	0.98	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	19.65	1.80	2.41	1.80	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	31.38	16.38	9.22	4.40	1.10	2.06
Olfactory epithelial cells, donor2	11934-125I8	25.48	11.15	7.82	2.32	0.87	2.75
Olfactory epithelial cells, donor3	11935-125I9	29.74	13.05	7.15	2.61	1.48	0.79
Olfactory epithelial cells, donor4	11936-126A1	28.63	9.74	9.64	3.80	0.58	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	21.06	4.21	3.01	1.20	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	15.53	4.89	2.77	1.70	1.06	0.21
Osteoblast - differentiated, donor2	11353-117H3	17.15	3.43	2.29	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.24	8.07	3.72	1.86	0.62	0.00
Osteoblast, donor1	11277-116H8	11.53	1.76	1.76	1.37	1.17	0.20
Osteoblast, donor2	11354-117H4	15.45	4.21	2.81	2.81	0.00	0.70
Osteoblast, donor3	11426-118G4	23.46	3.55	3.73	2.31	0.36	0.18
Pancreatic stromal cells, donor1	11249-116E7	22.74	3.96	5.14	1.18	0.34	0.59
Pericytes, donor1	11491-119E6	26.82	2.45	2.45	2.11	0.33	0.22
Pericytes, donor2	11571-120E5	22.64	5.89	2.04	1.81	0.45	0.23
Pericytes, donor3	11652-122E5	24.01	6.31	4.88	1.22	0.81	0.00
Perineurial Cells, donor1	11499-119F5	24.19	3.96	2.71	1.47	0.23	0.11
Perineurial Cells, donor2	11579-120F4	13.07	1.93	2.21	2.21	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	36.34	3.19	3.82	1.59	0.64	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	19.83	8.08	4.65	1.96	1.71	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	23.68	5.05	4.01	2.33	1.55	0.00
Placental Epithelial Cells, donor1	11278-116H9	16.02	2.63	2.15	7.65	1.20	0.00
Placental Epithelial Cells, donor2	11355-117H5	9.98	5.54	3.33	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	15.51	1.96	2.55	3.93	0.59	0.20
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	19.62	10.76	5.38	2.53	1.27	0.63
Preadipocyte - breast, donor1	11467-119B9	32.83	22.70	6.38	3.75	4.31	1.31
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	26.63	12.66	5.09	3.13	2.87	0.00
Preadipocyte - breast, donor2	11328-117E5	24.32	18.46	6.08	2.93	1.80	0.90
Preadipocyte - omental, donor1	11468-119C1	44.22	35.80	10.76	5.43	4.16	1.28
Preadipocyte - omental, donor2	11329-117E6	34.92	18.33	8.73	5.67	1.75	0.00
Preadipocyte - omental, donor3	11403-118D8	35.67	18.91	8.59	5.59	3.15	0.72
Preadipocyte - perirenal, donor1	11469-119C2	31.50	18.70	3.94	0.00	0.00	0.98
Preadipocyte - subcutaneous, donor1	11279-116I1	18.12	3.69	5.53	3.07	1.54	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	20.72	5.49	4.96	3.01	0.71	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	24.52	4.94	7.15	2.89	0.85	0.17
Preadipocyte - visceral, donor1	11280-116I2	20.77	5.59	5.03	2.14	1.02	0.00
Preadipocyte - visceral, donor2	11357-117H7	11.96	4.14	3.22	0.92	2.30	0.46
Preadipocyte - visceral, donor3	11429-118G7	16.82	4.18	3.55	1.67	0.42	0.31
Prostate Epithelial Cells (polarized), donor1	11253-116F2	19.16	4.37	1.51	2.72	0.15	0.30
Prostate Epithelial Cells, donor2	11331-117E8	17.20	4.06	3.79	1.22	0.14	0.68
Prostate Epithelial Cells, donor3	11404-118D9	25.17	2.76	4.53	2.14	0.18	0.37
Prostate Stromal Cells, donor1	11254-116F3	15.15	2.73	2.28	1.59	0.23	0.68
Prostate Stromal Cells, donor2	11332-117E9	19.01	5.38	3.41	1.79	0.72	0.54
Prostate Stromal Cells, donor3	11405-118E1	20.65	3.65	4.48	2.92	0.31	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	22.99	2.19	1.46	3.28	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	18.64	2.36	1.94	1.46	0.49	0.35
Renal Epithelial Cells, donor1	11517-119H5	16.74	1.52	1.52	3.55	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	24.90	2.85	2.13	2.85	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	22.87	3.07	3.49	2.33	0.00	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	19.06	2.72	3.40	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	17.92	3.64	4.18	1.35	0.27	0.00
Renal Glomerular Endothelial Cells, donor3	11675-122H1	11.99	2.89	0.67	1.33	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	20.63	2.66	3.33	0.67	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	21.57	1.54	1.54	1.76	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	21.32	1.88	1.88	4.39	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	17.48	2.77	4.72	2.77	0.28	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	29.26	4.83	4.03	3.76	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	27.83	3.37	2.11	3.80	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	15.62	3.47	1.74	1.54	0.00	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	19.71	2.33	1.04	2.85	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	31.27	5.40	1.99	3.98	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	15.44	1.03	2.06	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	9.79	4.01	0.75	1.25	0.75	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	26.73	8.02	4.01	2.81	1.20	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	12.51	5.36	1.79	2.68	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	6.05	6.60	3.30	0.55	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	9.86	9.28	5.80	0.00	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	18.98	7.67	2.86	1.43	0.26	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	11.32	5.76	3.08	0.60	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	15.39	6.02	4.46	1.56	0.56	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	19.23	6.57	3.72	0.74	0.87	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.38	5.94	3.96	0.58	0.47	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	15.02	5.78	4.39	0.69	0.46	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	14.38	8.08	3.01	0.41	0.27	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.16	3.33	3.78	0.91	0.45	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	17.92	5.73	1.79	0.72	0.90	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	12.05	9.32	2.87	0.14	0.43	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.74	6.65	3.86	0.86	0.43	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	11.95	7.97	3.76	1.33	1.11	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	11.28	8.22	3.25	0.00	0.57	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	14.07	5.59	3.54	1.02	0.84	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	16.16	8.46	3.95	1.32	0.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	15.13	7.43	2.39	0.53	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	16.06	7.30	4.09	0.97	0.29	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	15.09	6.49	3.44	0.95	0.76	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.95	6.51	3.20	0.96	0.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	12.89	6.73	4.48	0.56	1.12	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	16.75	6.15	4.79	0.68	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	9.48	6.56	3.46	1.09	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	13.61	5.89	3.56	1.23	0.86	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	15.85	5.78	4.16	0.81	0.81	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	10.61	7.78	2.12	0.94	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	12.10	8.13	4.96	0.79	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	13.80	7.02	4.68	2.10	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	11.61	9.54	3.94	0.41	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	13.05	6.42	2.21	1.55	0.44	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	10.86	5.85	4.80	2.51	0.42	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.15	7.81	2.56	0.81	0.40	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	13.45	4.26	4.60	1.36	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	12.72	5.01	4.05	1.35	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	10.83	8.42	3.09	1.03	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	10.42	6.31	3.29	1.37	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	11.98	6.40	3.94	0.82	0.99	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	10.40	6.82	3.92	0.17	0.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	15.24	4.44	5.03	0.59	1.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	12.26	6.66	5.06	0.53	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	14.93	6.78	4.29	0.97	0.55	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	11.91	3.57	2.86	0.48	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	13.30	5.44	4.64	1.21	1.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	9.89	4.90	2.45	0.38	0.94	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	16.07	5.94	5.94	0.70	1.75	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	8.16	5.74	2.72	0.60	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	7.59	4.53	1.96	0.49	0.24	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	20.52	11.94	5.68	1.16	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	11.56	10.34	3.65	1.22	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	8.14	3.01	2.11	0.00	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	9.73	5.88	3.39	0.23	0.90	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	18.87	5.09	5.39	1.50	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	14.52	6.85	2.24	0.59	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	13.66	7.26	2.77	0.85	1.07	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	19.23	7.21	1.80	1.80	0.00	0.00
Schwann Cells, donor1	11498-119F4	17.68	2.63	1.88	1.88	0.00	0.00
Schwann Cells, donor2	11578-120F3	23.82	0.00	3.40	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	13.36	1.97	1.10	0.44	0.44	0.44
Sebocyte, donor1	11220-116B5	64.64	9.86	10.96	2.19	1.10	0.55
Sebocyte, donor2	11301-117B5	25.74	5.06	8.27	0.00	1.38	1.38
Sebocyte, donor3	11378-118B1	33.39	4.33	7.01	1.03	0.82	0.41
Sertoli Cells, donor1	11255-116F4	28.16	3.31	11.60	3.31	1.66	0.00
Sertoli Cells, donor2	11333-117F1	36.72	8.47	0.00	0.00	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	23.84	3.43	3.61	2.73	0.53	0.26
Skeletal Muscle Cells, donor2	11358-117H8	9.40	3.61	5.78	0.00	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	10.87	3.34	2.51	0.84	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	18.69	3.93	2.83	4.24	0.63	0.31
Skeletal Muscle Cells, donor5	11455-119A6	20.66	4.01	3.27	2.08	0.74	0.15
Skeletal Muscle Cells, donor6	11459-119B1	26.47	6.00	3.08	2.92	0.62	0.15
Skeletal Muscle Satellite Cells, donor1	11240-116D7	33.90	5.17	4.03	3.53	0.63	0.13
Skeletal Muscle Satellite Cells, donor2	11321-117D7	25.54	4.99	2.71	2.57	0.14	0.86
Skeletal Muscle Satellite Cells, donor3	11397-118D2	28.57	8.14	4.17	3.08	0.69	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	21.99	4.80	4.38	4.55	0.59	0.51
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	2.17	0.72	0.72	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	14.04	4.95	2.89	1.65	0.28	0.41
Skin - palm, donor1	10286-104F7	61.78	16.12	8.06	13.43	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	12.83	2.02	2.02	0.72	0.00	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	44.98	19.63	13.09	7.36	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.33	2.34	2.47	0.52	0.13	0.78
Small Airway Epithelial Cells, donor1	11256-116F5	21.41	4.17	4.17	2.22	0.83	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	16.32	4.50	4.78	1.83	0.14	0.70
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	70.83	8.46	13.53	3.81	0.42	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	23.83	4.05	6.22	3.00	0.45	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	16.97	3.70	5.55	2.16	0.00	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	15.56	2.67	4.22	0.44	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	20.57	3.53	5.88	0.59	0.59	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	14.14	2.21	3.54	0.66	0.22	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	18.51	4.33	6.30	1.97	1.97	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	20.09	2.32	6.18	2.32	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	15.01	1.00	3.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	16.63	1.73	5.46	0.67	0.67	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	21.06	6.43	5.98	1.77	1.77	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	22.53	3.97	4.35	1.41	0.38	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.21	1.63	2.28	2.60	0.00	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	24.81	2.66	4.13	2.66	0.30	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	23.49	3.84	4.98	1.71	0.28	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	37.25	3.09	5.69	2.44	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.35	1.52	2.74	1.22	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	13.64	2.53	4.04	2.27	0.76	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	18.36	0.00	6.12	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.17	3.34	2.38	0.00	0.95	0.48
Smooth Muscle Cells - Colonic, donor1	11239-116D6	19.02	3.39	2.36	2.06	0.29	0.44
Smooth Muscle Cells - Colonic, donor2	11320-117D6	18.30	3.23	2.37	0.86	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	15.85	2.20	2.41	1.99	0.31	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	22.27	5.88	3.87	0.62	1.39	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	20.48	1.08	4.31	1.08	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	16.14	4.78	1.49	1.79	0.00	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	18.09	2.73	3.07	2.39	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	14.76	0.79	1.10	1.73	0.00	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	30.90	8.25	9.76	3.22	1.91	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	17.75	7.51	6.60	1.37	0.23	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	12.08	3.02	4.83	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	19.34	2.12	0.79	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	14.11	3.33	2.66	1.60	0.13	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	16.65	2.50	5.13	1.38	0.13	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	22.83	9.64	2.79	2.79	0.51	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	26.54	4.67	5.13	2.56	1.66	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	15.00	1.50	3.00	0.00	0.75	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	5.17	2.58	2.58	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	13.95	2.79	3.72	1.40	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	16.66	6.06	6.56	1.01	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	19.12	5.64	4.39	2.19	0.94	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	22.71	1.47	3.54	2.36	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	22.41	4.33	3.50	2.00	0.42	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	16.82	1.40	1.87	3.27	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	20.29	5.76	4.46	1.44	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	18.10	4.59	3.06	1.53	0.00	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	12.97	1.32	3.20	1.32	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	22.36	2.52	1.68	1.26	0.14	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	28.82	2.43	4.27	2.51	0.25	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	18.57	0.95	2.38	0.48	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	22.51	3.43	5.38	0.73	1.22	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.43	3.54	4.42	2.21	0.66	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	23.99	3.51	2.05	2.63	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	13.61	2.14	2.53	1.75	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	22.74	9.78	6.88	0.79	0.79	2.12
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	11.16	1.12	4.46	1.12	0.37	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	21.92	8.62	3.23	0.72	0.36	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	15.33	5.96	3.12	1.14	0.57	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	11.03	3.54	2.76	1.18	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	23.36	3.30	4.32	2.03	0.25	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	16.37	4.79	8.79	1.60	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	21.32	3.76	3.76	3.34	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	14.21	1.38	2.75	1.38	0.46	0.46
Synoviocyte, donor1	11291-117A4	30.97	17.17	6.23	3.03	2.36	1.35
Synoviocyte, donor2	11368-117I9	32.85	10.56	5.36	4.36	0.00	1.01
Synoviocyte, donor3	11440-118H9	17.87	5.81	4.92	1.79	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	22.51	2.50	2.14	1.07	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	35.68	1.98	5.95	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	18.52	1.85	3.24	0.93	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	21.08	2.94	2.80	1.15	0.36	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	18.17	1.16	2.71	1.16	0.77	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	12.60	1.72	1.72	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	31.13	7.75	4.67	3.69	0.49	0.25
Urethra, donor2	10319-105A4	37.77	12.59	7.19	7.19	0.00	0.00
Urothelial Cells, donor1	11520-119H8	24.44	3.72	3.98	1.06	0.53	0.27
Urothelial Cells, donor2	11600-120H7	12.02	2.40	1.60	1.20	0.00	0.00
Urothelial Cells, donor3	11681-122H7	8.94	0.92	0.69	1.38	0.69	0.00
Urothelial cells, donor0	11216-116B1	13.37	0.67	1.56	0.45	0.45	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	8.01	0.89	1.78	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	5.72	1.43	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	7.53	0.68	0.00	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	11.71	3.79	1.72	1.38	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	18.01	3.49	1.74	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	15.62	4.16	2.08	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	8.26	3.67	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	4.56	2.74	0.00	0.00	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	0.12	0.00	0.00	0.00	0.00	0.00
Wilms' tumor cell line:HFWT	10597-108E3	63.36	9.68	2.64	1.76	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	15.08	2.51	1.68	1.40	0.28	0.00
achilles tendon, donor2	10292-104G4	18.60	8.27	4.13	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	34.93	6.63	2.04	3.31	0.25	0.51
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	37.61	6.50	3.02	3.71	0.46	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.36	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	61.23	11.97	5.17	5.71	0.00	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	47.22	8.71	7.31	6.75	0.28	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.00	0.00	0.00	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	60.37	11.02	6.61	3.08	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	13.07	2.86	1.63	0.82	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	3.88	0.39	1.16	0.39	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	26.13	3.31	3.13	3.50	0.00	0.55
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	0.00	0.00	0.00	0.23	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.26	0.00	0.00	0.26	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	12.27	0.58	1.46	1.17	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	16.73	7.90	3.25	2.32	0.46	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.20	3.07	7.98	2.46	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	36.27	9.39	5.12	2.13	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	30.94	5.76	8.19	1.52	0.30	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	29.61	8.18	6.98	2.41	0.96	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	17.60	2.23	2.45	2.90	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.30	1.51	3.01	0.38	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	20.93	9.59	4.80	4.36	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	0.00	0.00	0.00	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	0.00	0.00	0.00	0.00	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	31.33	9.31	2.48	3.10	0.47	0.16
adipose, donor1	10184-103D4	77.41	29.91	0.00	3.52	1.17	1.76
adipose, donor2	10185-103D5	40.15	10.95	0.81	2.03	0.00	1.22
adipose, donor3	10186-103D6	33.76	12.25	0.82	2.45	0.27	0.27
adipose, donor4	10187-103D7	21.67	10.40	0.00	3.47	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	3.95	0.16	0.00	0.32	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	14.55	7.28	7.28	3.64	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	10.72	2.14	2.50	0.71	0.00	0.36
amniotic membrane cells, donor1	12235-129G3	27.36	4.87	7.19	6.96	0.70	0.00
amniotic membrane cells, donor2	12236-129G4	25.02	4.40	3.72	7.44	0.00	0.68
amniotic membrane cells, donor3	12237-129G5	31.23	3.24	7.07	4.42	0.29	0.00
amygdala - adult, donor10196	10167-103B5	46.25	9.49	21.34	4.74	1.19	0.00
amygdala, adult, donor10252	10151-102I7	45.42	9.33	21.90	3.85	0.41	0.20
amygdala, newborn, donor10223	10360-105E9	14.85	4.84	11.94	1.29	0.97	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	50.93	7.39	3.95	2.29	0.13	0.00
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1.67	0.00	0.00	1.00	0.00	0.00
aorta, adult, pool1	10052-101G7	31.97	7.45	4.51	3.53	0.20	0.20
appendix, adult	10189-103D9	30.66	6.60	5.43	3.88	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	28.53	4.08	2.72	1.36	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	0.87	0.29	0.14	0.29	0.00	0.00
b cell line:RPMI1788	10427-106D4	38.81	8.92	3.87	4.61	1.78	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	46.06	15.26	6.94	1.94	1.66	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	18.46	10.22	5.06	3.77	0.89	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	26.28	2.68	1.51	0.67	0.33	0.50
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1.12	0.56	0.00	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	41.39	4.45	4.24	3.80	0.33	0.11
blood, adult, pool1	10053-101G8	13.29	0.00	4.43	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	27.40	7.71	1.71	2.57	0.00	0.00
bone marrow, adult	10192-103E3	13.50	6.07	3.37	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	27.68	9.23	25.63	5.13	0.00	0.00
brain, adult, pool1	10012-101C3	49.78	6.46	23.39	3.79	1.78	1.00
brain, fetal, pool1	10085-102B4	48.09	2.67	8.01	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	26.43	10.57	7.93	7.60	0.99	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	14.35	1.37	1.87	0.62	0.00	0.00
breast, adult, donor1	10080-102A8	15.78	6.31	3.79	4.42	1.89	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	16.77	2.16	1.14	1.78	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	15.15	7.11	4.02	1.24	0.31	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	31.08	7.83	5.06	2.53	0.00	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	9.44	4.12	2.42	0.24	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	30.56	1.41	0.47	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	11.27	2.73	1.20	1.64	0.22	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	28.52	1.90	1.58	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	23.16	3.19	1.86	2.66	0.53	0.27
caudate nucleus - adult, donor10196	10177-103C6	49.51	2.30	9.21	1.15	0.00	2.30
caudate nucleus, adult, donor10252	10164-103B2	42.33	4.35	10.04	5.52	0.17	0.00
caudate nucleus, adult, donor10258	10379-105H1	38.97	4.58	3.82	4.58	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	20.14	4.03	4.76	1.83	0.37	0.37
cerebellum - adult, donor10196	10173-103C2	81.57	26.22	17.48	8.74	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	53.59	26.05	16.44	3.63	1.49	0.21
cerebellum, adult, pool1	10083-102B2	38.98	9.31	8.97	2.41	1.03	0.34
cerebellum, newborn, donor10223	10357-105E6	51.48	25.74	6.64	0.00	0.83	1.66
cerebral meninges, adult	10188-103D8	43.12	8.57	19.16	3.28	2.02	0.25
cerebrospinal fluid, donor2	10294-104G6	21.93	2.19	7.31	1.46	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	34.22	8.05	3.59	4.60	0.29	0.29
cervical cancer cell line:ME-180	10553-107I4	19.22	6.46	2.98	2.98	0.83	0.33
cervix, adult, pool1	10013-101C4	43.26	7.77	5.14	5.56	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	38.46	18.25	6.27	3.48	2.37	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	1.31	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	35.42	12.05	2.11	2.73	0.00	0.75
choriocarcinoma cell line:SCH	10785-110H2	89.82	9.36	8.50	4.31	0.12	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	17.31	10.44	1.42	0.95	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	19.66	3.13	2.85	5.41	0.57	0.57
chorionic membrane cells, donor2	12239-129G7	29.63	6.46	4.08	3.68	0.50	0.50
chorionic membrane cells, donor3	12240-129G8	29.67	3.30	2.75	4.40	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	10.10	2.02	0.00	2.02	0.00	1.01
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	20.55	4.80	4.42	2.50	0.00	0.19
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	13.30	1.27	1.69	1.69	0.00	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	3.08	0.26	0.26	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	2.66	0.24	0.48	0.73	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	2.24	0.20	0.41	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	30.03	3.83	6.18	2.94	0.59	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	0.00	0.00	0.00	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	24.00	4.34	3.43	0.69	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	29.50	9.89	4.68	5.55	0.35	0.52
colon carcinoma cell line:CACO-2	10513-107D9	41.37	13.55	1.83	2.01	0.55	0.18
colon carcinoma cell line:COLO-320	10420-106C6	45.23	15.96	2.28	2.66	0.00	0.00
colon, adult, donor1	10082-102B1	13.09	2.38	1.19	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	19.86	2.35	2.47	2.47	0.00	0.12
colon, fetal, donor1	10070-101I7	13.60	3.09	0.62	1.85	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	9.17	0.00	0.00	4.58	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	18.70	8.07	2.97	2.55	3.82	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	9.51	4.23	2.41	1.66	2.26	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	13.26	5.50	3.24	1.55	2.12	0.00
corpus callosum, adult, pool1	10042-101F6	77.28	15.04	10.06	3.65	0.77	0.00
cruciate ligament, donor2	10295-104G7	32.42	18.64	7.29	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	20.06	6.42	1.61	5.62	0.00	0.00
diencephalon, adult	10193-103E4	31.68	9.12	5.04	0.96	0.72	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	30.08	7.12	0.92	2.98	0.46	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	15.64	3.08	2.05	3.59	0.00	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	7.22	2.41	2.17	0.72	0.48	0.00
ductus deferens, adult	10196-103E7	16.45	5.98	2.99	3.99	1.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	25.92	2.88	4.32	1.44	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	19.86	11.03	3.68	3.68	0.00	0.74
dura mater, adult, donor1	10041-101F5	52.28	6.28	8.34	3.47	1.32	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	13.77	15.32	1.11	2.00	0.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	21.64	11.32	1.58	2.58	0.00	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	28.36	8.63	4.32	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	29.06	1.21	3.33	2.12	0.00	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	28.40	6.79	5.25	2.16	0.62	0.00
embryonic pancreas cell line:2C6	10603-108E9	43.34	6.57	7.88	3.94	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	45.92	10.06	3.02	3.35	0.00	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	1.63	0.00	0.18	0.36	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	28.30	6.59	5.31	1.29	0.64	1.13
epidermoid carcinoma cell line:A431	10426-106D3	25.68	4.56	3.33	1.89	0.44	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	20.46	4.18	2.20	1.32	0.11	0.00
epididymis, adult	10197-103E8	33.07	9.00	7.95	4.40	0.84	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	31.05	4.26	3.73	0.89	0.35	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	15.34	1.57	1.18	1.57	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	13.10	4.06	2.75	0.26	0.26	0.26
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	10.92	3.44	2.76	1.08	0.20	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	12.55	3.36	2.58	1.57	0.11	0.22
esophagus, adult, pool1	10015-101C6	32.60	4.67	3.50	3.19	0.11	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	13.90	1.00	3.51	0.38	0.50	0.13
eye - muscle inferior rectus, donor1	10272-104E2	21.73	2.41	2.41	2.41	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	18.94	4.21	0.00	12.63	0.00	0.00
eye - muscle medial, donor2	10299-104H2	25.30	10.42	2.98	2.98	0.00	0.00
eye - muscle superior, donor2	10297-104G9	42.42	8.03	4.59	5.73	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	18.95	4.37	5.83	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	27.97	5.08	4.58	2.54	0.00	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	17.31	3.59	1.92	1.80	0.13	0.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	24.45	5.46	2.85	1.90	0.71	0.00
frontal lobe, adult, pool1	10040-101F4	76.19	9.66	31.52	5.35	3.47	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	43.54	17.71	5.10	2.10	0.00	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	37.95	9.24	2.01	1.37	0.18	0.00
gall bladder, adult	10198-103E9	40.32	5.07	5.79	3.62	0.72	0.24
gamma delta positive T cells, donor1	11937-126A2	1.07	0.00	1.07	0.54	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	2.99	0.37	1.12	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	15.84	10.56	5.07	3.38	1.27	0.84
gastric adenocarcinoma cell line:MKN45	10612-108F9	2.71	0.19	0.58	0.19	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	0.00	0.00	0.00	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	39.07	31.07	2.97	2.06	0.69	0.69
giant cell carcinoma cell line:LU65	10487-107B1	13.08	3.33	1.15	1.03	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	26.17	4.62	3.92	2.24	0.28	0.00
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.71	5.74	2.74	3.49	0.25	0.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	9.92	2.53	2.96	1.79	0.00	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	9.13	3.09	2.67	1.12	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	0.22	0.11	0.00	0.11	0.00	0.00
glioma cell line:GI-1	10413-106B8	15.82	1.46	2.05	0.29	0.29	0.29
globus pallidus - adult, donor10196	10175-103C4	45.19	6.56	5.10	0.73	0.00	0.73
globus pallidus, adult, donor10252	10161-103A8	43.94	8.30	5.61	3.42	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	38.34	8.22	4.11	4.11	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.99	6.40	1.60	2.13	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	159.06	17.13	2.45	41.60	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	26.13	0.00	0.00	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	28.48	6.40	5.44	4.16	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	23.87	15.61	0.46	2.75	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	20.12	13.72	0.46	0.91	0.00	0.91
hIPS +CCl2, biol_rep3	14385-156C2	20.61	13.53	1.29	1.93	0.00	0.00
hIPS, biol_rep1	14380-156B6	8.62	11.50	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	8.23	13.03	0.00	2.06	0.00	0.69
hIPS, biol_rep3	14382-156B8	32.00	6.62	2.21	3.31	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	2.01	0.00	0.00	0.57	0.00	0.00
heart - mitral valve, adult	10205-103F7	30.20	8.97	5.68	3.29	0.60	0.00
heart - pulmonic valve, adult	10206-103F8	37.91	6.80	7.06	3.92	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	23.31	13.32	3.33	4.16	0.83	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	21.63	4.08	4.29	1.63	1.02	0.20
heart, adult, diseased, donor1	10051-101G6	25.12	4.26	4.68	2.98	1.28	0.00
heart, adult, pool1	10016-101C7	35.42	3.68	3.68	5.06	0.69	0.00
heart, fetal, pool1	10046-101G1	51.24	8.83	4.00	6.37	0.41	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	14.50	5.24	4.94	1.23	0.62	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	19.03	7.14	1.19	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.99	0.22	0.00	0.11	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.73	0.24	0.00	0.24	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.51	0.20	0.10	0.40	0.00	0.00
hepatoma cell line:Li-7	10484-107A7	5.23	1.22	0.56	0.33	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	21.71	7.04	2.91	2.41	0.20	0.00
hippocampus - adult, donor10196	10169-103B7	57.73	10.41	16.09	7.57	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	41.23	10.61	13.06	4.08	0.82	0.00
hippocampus, adult, donor10258	10374-105G5	45.81	4.98	16.93	2.49	0.50	0.50
hippocampus, newborn, donor10223	10363-105F3	23.62	4.93	13.04	3.88	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	32.35	19.53	0.00	0.61	0.00	1.83
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	21.99	11.78	0.59	0.59	0.20	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	29.96	13.46	1.02	3.30	0.25	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	38.91	11.84	1.69	0.56	0.00	1.13
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	39.25	14.46	1.03	1.81	0.00	6.97
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	47.83	12.91	1.14	0.38	0.00	1.90
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	34.74	11.39	0.88	2.04	0.29	1.46
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	43.52	12.28	1.72	2.37	0.43	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	30.45	9.18	1.25	2.92	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	26.52	10.89	1.66	0.47	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	30.38	12.05	3.21	1.45	0.32	0.80
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	36.36	14.81	2.69	3.37	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	30.36	10.48	0.47	1.56	0.00	0.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	26.53	11.30	0.00	0.49	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	27.93	10.47	0.00	1.75	0.00	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	45.25	15.46	0.76	0.76	0.00	1.72
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	40.55	11.34	1.31	0.87	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	32.98	11.49	1.50	1.50	0.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	54.07	9.23	1.51	1.32	0.57	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	69.12	16.37	1.36	1.36	0.45	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	48.24	17.54	0.63	0.31	0.00	1.57
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	26.94	12.08	2.45	1.47	0.16	0.65
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	30.19	10.45	2.03	0.87	0.29	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	24.81	11.66	1.49	0.60	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	26.60	11.82	0.55	1.11	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	26.82	11.41	0.57	0.86	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	33.48	17.56	1.22	1.22	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	35.91	10.21	1.76	2.46	0.70	3.87
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	27.87	10.77	0.32	1.58	0.00	0.95
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	35.10	14.22	1.21	2.42	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	46.02	10.34	2.59	0.52	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	37.86	15.28	0.66	2.66	0.66	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	36.43	11.29	2.82	2.31	0.00	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	25.82	9.46	1.53	1.53	0.00	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	25.75	14.39	3.79	2.27	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	21.84	9.07	3.36	1.68	0.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	30.19	10.14	0.72	2.17	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	20.50	14.26	0.45	1.34	0.00	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	21.95	11.22	0.00	1.46	0.00	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	50.73	16.20	2.44	1.53	0.31	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	52.05	68.32	3.25	3.25	0.00	6.51
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	46.99	20.52	0.99	2.98	0.00	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	53.09	10.95	1.09	1.64	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	49.94	10.86	2.17	1.09	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	39.15	15.66	1.78	2.49	0.36	1.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	10.74	16.71	1.19	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	32.50	11.10	2.30	1.63	0.27	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	14.01	8.35	1.35	1.35	0.00	0.54
immature langerhans cells, donor1	11904-125F5	82.57	49.16	10.90	5.33	9.20	0.48
immature langerhans cells, donor2	11905-125F6	38.02	13.47	8.71	3.96	3.17	0.00
insula, adult, pool1	10039-101F3	82.14	10.50	37.47	5.96	3.12	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	12.03	3.90	3.58	2.28	0.00	0.00
kidney, adult, pool1	10017-101C8	27.54	7.21	6.91	4.31	1.50	0.20
kidney, fetal, pool1	10045-101F9	31.55	6.22	4.03	4.81	0.42	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	21.45	1.99	3.27	6.25	0.57	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	9.26	1.66	3.18	0.69	0.14	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	41.29	6.79	2.94	3.49	0.00	0.37
left atrium, adult, donor1	10079-102A7	19.07	7.08	1.63	2.18	0.00	1.09
left ventricle, adult, donor1	10078-102A6	12.64	1.52	2.02	3.54	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	0.00	0.00	0.00	0.27	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	18.68	2.16	3.59	0.00	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	16.30	3.80	5.98	2.72	1.09	0.54
leiomyoma cell line:15425	10571-108B4	15.05	4.86	5.10	2.43	0.49	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	12.70	6.35	12.70	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	9.41	2.09	2.09	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	0.71	0.12	0.00	0.83	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	17.34	4.53	3.59	1.25	0.47	0.16
liposarcoma cell line:SW 872	10726-110A6	9.87	0.97	0.73	0.37	0.00	0.00
liver, adult, pool1	10018-101C9	17.99	5.83	4.70	1.46	0.97	0.32
liver, fetal, pool1	10086-102B5	5.64	6.58	4.70	0.00	0.00	0.94
locus coeruleus - adult, donor10196	10182-103D2	37.04	10.06	6.85	2.48	1.02	0.15
locus coeruleus, adult, donor10252	10165-103B3	40.79	7.20	7.01	0.92	0.37	0.37
locus coeruleus, adult, donor10258	10375-105G6	32.45	4.80	7.90	2.54	0.00	0.28
locus coeruleus, newborn, donor10223	10362-105F2	19.35	7.15	2.94	0.84	1.26	0.42
lung adenocarcinoma cell line:A549	10499-107C4	19.38	4.29	2.49	1.94	0.55	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	18.61	13.10	4.14	4.14	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	35.33	8.04	2.37	3.43	0.13	0.13
lung, adult, pool1	10019-101D1	35.32	6.38	3.78	3.19	0.95	0.24
lung, fetal, donor1	10068-101I5	66.50	17.12	4.57	5.99	0.86	0.86
lung, right lower lobe, adult, donor1	10075-102A3	14.66	5.50	5.50	3.21	0.92	0.46
lymph node, adult, donor1	10077-102A5	10.89	3.31	3.31	1.42	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	13.81	3.07	2.19	2.41	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	36.07	14.64	3.92	4.83	0.75	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	22.09	13.59	7.65	3.40	0.85	0.00
mature adipocyte, donor1	12231-129F8	66.60	16.87	3.55	4.88	1.33	0.00
mature adipocyte, donor2	12232-129F9	60.18	16.60	6.43	4.98	2.49	0.21
mature adipocyte, donor3	12233-129G1	64.01	17.07	8.53	5.69	1.66	0.47
mature adipocyte, donor4	12234-129G2	52.91	17.64	5.53	3.69	2.37	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	25.97	8.82	5.24	3.34	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	66.55	14.66	41.74	3.38	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	39.17	15.08	23.36	3.86	3.86	0.18
medial frontal gyrus, adult, donor10258	10368-105F8	40.98	12.39	20.97	4.13	0.95	0.64
medial frontal gyrus, newborn, donor10223	10352-105E1	39.66	12.79	12.79	2.99	2.13	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	49.61	11.48	24.47	3.54	2.70	6.24
medial temporal gyrus, adult, donor10252	10156-103A3	40.96	14.43	26.53	3.82	4.46	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	38.53	11.56	11.56	5.78	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	43.06	28.71	28.71	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	29.07	7.54	13.28	1.44	1.44	0.36
medulla oblongata - adult, donor10196	10174-103C3	24.01	1.95	3.89	1.30	1.30	0.65
medulla oblongata, adult, donor10252	10155-103A2	27.40	6.66	5.73	2.17	0.31	0.00
medulla oblongata, adult, pool1	10038-101F2	51.59	10.20	10.86	2.69	0.82	0.00
medulla oblongata, newborn, donor10223	10361-105F1	19.09	4.51	4.86	0.69	1.04	0.00
medulloblastoma cell line:D283 Med	10838-111E1	41.40	10.18	2.88	4.43	0.00	0.89
medulloblastoma cell line:ONS-76	10759-110E3	9.54	1.96	0.86	0.61	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	8.05	3.59	2.30	0.57	0.00	0.14
melanoma cell line:G-361	10465-106H6	17.10	2.99	6.52	0.54	0.00	0.27
meningioma cell line:HKBMM	10691-109F7	14.29	1.99	1.63	1.09	0.00	0.36
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	21.00	4.67	1.81	1.81	0.26	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	21.17	4.60	4.91	2.30	1.69	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	22.90	4.73	4.00	0.91	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	13.25	7.04	4.14	0.83	2.07	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	20.51	2.25	5.20	1.97	0.14	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	17.14	3.47	4.24	2.70	0.96	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	4.16	6.25	0.69	0.00	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.97	7.72	5.84	2.23	0.34	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	25.76	4.60	5.75	2.99	1.04	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.31	3.45	4.24	1.59	0.13	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.83	5.54	4.59	1.22	0.81	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	18.35	3.27	6.54	2.28	0.71	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	16.80	4.61	6.26	2.96	2.96	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	18.82	4.57	6.50	2.63	0.55	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	25.48	3.49	7.68	4.19	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.99	5.10	6.12	1.84	0.20	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	12.58	3.95	4.31	1.44	1.08	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	21.83	1.66	4.14	2.90	0.31	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.33	4.33	7.75	1.82	1.60	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	20.56	7.55	2.94	2.10	0.42	1.68
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	19.43	2.99	4.48	2.39	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.51	2.28	4.29	1.66	0.26	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	29.08	4.79	7.36	4.42	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.45	5.15	9.16	2.86	1.72	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	11.79	7.16	2.95	1.26	0.00	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	20.55	5.48	2.28	3.20	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	15.35	3.58	2.56	2.30	0.51	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	19.63	5.50	4.19	1.57	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	12.94	4.93	2.77	1.85	0.00	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.77	5.41	4.00	0.47	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	12.86	5.08	1.69	2.71	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	18.08	5.50	5.11	2.36	1.18	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	15.29	4.63	1.85	1.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	18.75	6.06	3.46	3.75	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.51	6.25	3.57	2.01	0.67	0.45
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.42	4.81	5.05	2.64	0.48	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	20.53	8.80	4.40	3.67	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	14.10	2.01	2.01	2.01	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	12.28	3.68	4.09	2.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	13.75	3.87	4.73	1.29	0.00	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	5.47	8.20	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	19.81	6.17	2.60	2.60	0.00	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	20.37	8.73	1.45	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.06	4.80	3.20	1.60	0.00	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	22.08	8.18	2.45	1.64	0.82	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	18.66	9.33	3.11	1.55	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	20.99	2.10	2.10	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	14.90	2.98	2.98	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	14.30	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.23	2.37	3.56	2.37	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	1.22	2.44	4.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	10.77	3.17	1.27	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	11.73	2.76	2.07	1.38	0.69	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	0.00	2.15	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	0.00	7.98	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	6.89	3.44	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	10.59	0.81	1.63	1.22	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	11.12	1.59	0.79	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	7.07	1.77	1.77	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	10.91	2.49	2.49	1.25	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	14.70	5.35	1.34	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	13.01	0.00	5.91	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	23.11	5.14	5.14	5.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	4.13	2.75	4.82	2.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	17.32	7.42	2.97	2.97	1.48	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	21.31	8.97	1.12	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	19.72	5.09	4.45	1.91	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	16.52	7.25	2.01	2.42	1.21	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	15.26	8.72	2.18	8.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	15.20	7.60	1.27	2.53	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	26.10	4.25	2.43	2.43	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	18.08	13.56	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	15.65	6.59	2.47	3.29	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	16.87	5.56	1.98	2.78	0.79	0.79
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	14.60	5.52	3.24	2.92	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	13.24	7.13	1.02	3.06	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	40.23	19.34	9.28	5.42	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	47.72	4.72	4.49	4.25	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	40.08	7.65	5.56	3.71	0.00	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	4.27	12.82	4.27	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	7.19	4.83	1.44	0.62	0.10	0.51
mesothelioma cell line:Mero-25	10850-111F4	9.08	3.40	1.36	2.27	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	2.69	0.49	0.00	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	16.61	3.32	3.54	3.54	0.00	0.22
mesothelioma cell line:Mero-82	10853-111F7	11.04	1.58	2.10	0.79	0.79	0.00
mesothelioma cell line:Mero-83	10854-111F8	20.77	5.28	5.11	1.19	0.34	0.00
mesothelioma cell line:Mero-84	10855-111F9	4.55	0.00	0.25	5.81	0.00	0.25
mesothelioma cell line:Mero-95	10856-111G1	20.70	1.86	5.80	1.86	0.21	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	16.40	7.12	3.81	2.82	0.00	0.00
mesothelioma cell line:NCI-H226	10846-111E9	13.21	3.62	1.45	1.81	0.36	0.18
mesothelioma cell line:NCI-H2452	10848-111F2	6.66	1.37	1.37	1.37	0.00	0.00
mesothelioma cell line:NCI-H28	10845-111E8	21.38	13.23	1.78	3.31	0.51	0.51
mesothelioma cell line:No36	10857-111G2	9.13	1.96	2.28	0.65	0.00	0.33
mesothelioma cell line:ONE58	10858-111G3	8.67	1.63	0.54	1.35	0.81	0.27
migratory langerhans cells, donor1	11901-125F2	22.26	8.44	3.07	4.03	3.45	0.00
migratory langerhans cells, donor2	11902-125F3	20.39	6.35	1.59	4.15	2.81	0.12
migratory langerhans cells, donor3	11903-125F4	36.97	11.31	4.13	6.64	3.05	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	29.38	4.24	1.63	1.63	0.00	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	27.76	6.99	1.91	2.33	0.00	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	3.23	0.69	0.46	0.23	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	0.00	0.00	0.00	0.19	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	74.10	15.71	10.35	2.03	0.37	0.37
myeloma cell line:PCM6	10474-106I6	8.10	0.79	1.38	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	46.67	16.23	11.16	3.04	0.51	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	19.81	9.61	7.65	0.78	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	29.53	1.78	3.57	3.79	0.33	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.90	2.35	3.53	2.50	0.22	0.15
nasal epithelial cells, donor2	12227-129F4	36.98	3.31	8.28	3.31	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	35.66	5.98	4.37	5.06	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	57.25	15.53	7.11	5.43	0.75	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	16.45	3.80	1.27	1.05	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	25.72	3.35	1.30	1.12	0.19	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	20.16	1.19	2.14	1.66	0.00	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	0.32	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	0.00	0.00	0.00	0.40	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	9.54	0.00	3.18	0.64	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.70	6.39	3.99	1.60	0.53	0.53
neutrophil PMN, donor1	12133-128D9	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	81.69	17.42	0.68	3.55	0.68	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	27.22	8.01	1.60	3.20	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.71	3.85	2.24	1.92	0.32	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	0.26	0.00	0.00	0.00	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	67.12	9.19	22.40	5.06	1.87	0.37
occipital cortex - adult, donor10196	10172-103C1	63.87	14.42	51.51	8.24	6.18	0.00
occipital cortex, adult, donor10252	10163-103B1	51.79	12.34	24.15	5.10	3.76	0.27
occipital cortex, newborn, donor10223	10355-105E4	28.02	9.10	17.11	2.91	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	41.72	10.23	20.20	4.99	1.84	0.52
occipital lobe, fetal, donor1	10073-102A1	26.60	2.57	8.15	1.72	0.00	0.00
occipital pole, adult, pool1	10036-101E9	61.50	9.46	28.86	4.26	4.10	0.39
olfactory region, adult	10195-103E6	43.18	8.02	20.25	2.10	1.15	0.00
optic nerve, donor1	10277-104E7	70.04	12.01	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	9.34	1.48	1.25	1.14	0.00	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	28.30	2.34	0.69	2.06	0.14	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	10.16	2.88	1.35	2.20	0.00	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	13.28	3.23	2.54	2.43	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	12.93	2.35	2.35	2.65	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	53.26	11.21	4.67	3.74	0.93	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	18.87	5.73	3.82	4.24	0.00	0.21
ovary, adult, pool1	10020-101D2	30.75	2.45	3.06	3.23	0.17	0.00
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	26.21	5.87	2.38	1.10	0.00	0.00
pancreas, adult, donor1	10049-101G4	21.63	4.70	4.70	2.82	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	26.00	14.54	2.52	1.40	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	15.84	3.75	2.73	2.38	0.17	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	8.28	1.16	1.32	0.99	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	71.48	8.42	31.48	3.39	2.38	0.18
parietal cortex, adult, donor10258	10373-105G4	27.89	6.61	11.74	4.40	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	51.73	12.23	21.63	7.52	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	40.76	13.11	23.09	4.28	2.28	0.00
parietal lobe, adult, pool1	10034-101E7	66.44	10.75	30.14	5.38	3.44	0.26
parietal lobe, fetal, donor1	10072-101I9	25.22	5.82	7.76	2.91	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	28.41	5.61	11.96	1.12	0.75	0.37
parotid gland, adult	10199-103F1	20.97	3.08	4.32	1.85	0.00	0.00
penis, adult	10200-103F2	27.39	10.21	4.30	3.22	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.37	0.00	0.00	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	9.03	1.31	1.31	1.17	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	12.90	0.65	1.94	1.29	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	13.03	0.00	2.37	1.18	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	11.29	1.25	2.51	1.88	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	42.50	11.13	7.08	10.12	2.02	0.00
pituitary gland, adult, donor10252	10162-103A9	71.40	16.16	14.59	4.69	1.04	0.00
pituitary gland, adult, donor10258	10378-105G9	44.26	13.62	9.36	1.70	0.00	0.85
placenta, adult, pool1	10021-101D3	19.67	3.23	2.47	1.40	0.43	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	16.69	4.37	0.93	0.66	0.26	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	1.87	0.93	0.47	0.47	0.00	0.00
pons, adult, pool1	10033-101E6	54.05	10.24	15.23	2.84	1.55	0.09
postcentral gyrus, adult, pool1	10032-101E5	61.72	9.50	31.82	4.36	2.44	0.61
promyelocytes/myelocytes PMC, donor1	12132-128D8	41.83	6.27	0.00	12.55	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	5.51	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	11.74	0.00	0.00	11.74	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	25.64	3.35	2.77	1.17	0.44	0.29
prostate cancer cell line:PC-3	10439-106E7	31.76	5.08	5.63	1.82	0.18	0.36
prostate, adult, pool1	10022-101D4	29.29	5.53	3.72	2.99	0.36	0.09
putamen, adult, donor10196	10176-103C5	55.00	3.54	9.44	4.25	0.00	0.00
putamen, adult, donor10252	10152-102I8	64.70	5.88	3.92	5.88	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	25.13	3.28	1.09	2.19	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	28.75	1.69	4.59	1.93	0.24	0.24
putamen, newborn, donor10223	10365-105F5	8.25	9.00	3.00	1.50	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	10.47	1.45	0.29	1.16	0.29	0.00
rectum, fetal, donor1	10067-101I4	36.17	6.95	5.56	2.78	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	13.99	3.18	1.70	1.06	0.42	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	24.44	1.24	1.24	0.41	0.41	0.83
retina, adult, pool1	10030-101E3	27.24	5.37	6.36	1.79	0.40	0.10
retinoblastoma cell line:Y79	10475-106I7	2.34	0.00	0.26	0.26	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	0.00	0.00	0.00	0.12	0.00	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	16.87	3.37	1.41	0.84	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	27.28	3.03	3.79	3.03	0.00	0.76
salivary acinar cells, donor1	11771-123I7	23.79	3.08	10.68	1.13	0.81	0.49
salivary acinar cells, donor2	11772-123I8	27.12	6.06	7.30	1.79	1.38	0.41
salivary acinar cells, donor3	11773-123I9	33.10	8.61	9.93	3.31	0.66	0.00
salivary gland, adult, pool1	10093-102C3	24.59	5.72	5.15	1.72	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	25.80	1.35	5.90	1.26	0.51	0.08
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	24.22	2.23	6.11	1.88	0.24	0.47
seminal vesicle, adult	10201-103F3	27.51	2.12	3.70	2.12	0.53	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	37.65	29.64	13.85	12.63	3.40	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	19.38	3.27	4.03	1.76	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	21.07	4.01	2.01	1.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	14.78	2.69	1.21	1.07	0.27	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	0.00	0.00	0.00	0.22	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	7.74	1.55	1.81	1.42	0.39	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	86.54	12.77	4.26	9.22	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	24.59	7.80	2.64	2.04	0.84	0.12
skeletal muscle, fetal, donor1	10066-101I3	20.10	6.03	2.01	3.02	0.00	1.01
skin, adult, donor1	10074-102A2	27.14	6.79	6.79	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	31.56	6.31	6.94	1.89	0.00	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	27.02	14.34	3.34	4.67	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	23.64	13.24	4.10	1.26	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.77	0.00	0.39	0.19	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	24.56	10.88	3.46	1.81	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	55.98	7.08	0.97	4.02	0.00	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	10.46	10.46	2.18	0.87	0.22	0.22
small intestine, adult, pool1	10024-101D6	7.76	2.15	2.51	1.43	0.24	0.00
small intestine, fetal, donor1	10064-101I1	9.09	1.97	2.70	1.97	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	15.39	14.87	3.08	2.05	0.00	1.03
smooth muscle, adult, pool1	10048-101G3	51.69	7.24	3.62	6.98	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	26.00	10.45	2.41	2.14	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	32.12	6.42	5.05	1.61	0.23	0.23
spinal cord, adult, donor10252	10159-103A6	45.34	7.89	5.91	1.18	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	25.60	7.61	4.84	0.00	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	45.74	9.76	11.59	3.05	1.83	0.00
spinal cord, newborn, donor10223	10359-105E8	32.60	11.02	3.67	2.30	1.38	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	17.18	4.78	2.99	1.94	0.45	0.30
spleen, adult, pool1	10025-101D7	24.78	6.06	5.95	4.07	0.66	0.11
spleen, fetal, pool1	10044-101F8	38.22	8.50	5.16	5.32	0.48	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	22.26	4.76	1.97	1.14	0.21	0.31
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	26.01	3.61	3.61	1.71	0.19	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	25.51	7.34	3.84	1.05	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.46	3.91	1.17	1.95	0.00	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	19.14	5.74	2.93	2.59	0.23	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	9.74	2.97	0.85	1.69	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	16.08	11.42	5.08	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	54.47	3.20	7.48	8.54	0.00	0.00
submaxillary gland, adult	10202-103F4	21.08	6.27	3.42	1.71	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	37.59	8.10	5.40	2.70	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	33.62	9.31	9.31	1.03	0.52	0.00
substantia nigra, newborn, donor10223	10358-105E7	16.96	12.72	2.83	0.71	0.71	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	32.56	10.32	2.52	3.90	0.23	0.23
temporal lobe, adult, pool1	10031-101E4	61.20	8.14	25.69	4.49	2.03	0.51
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	34.19	3.56	7.83	1.42	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	36.92	3.08	6.59	1.32	0.00	0.00
tenocyte, donor1	11763-123H8	30.72	8.73	5.93	4.89	0.35	1.05
tenocyte, donor2	11765-123I1	25.94	4.20	3.43	3.43	0.38	0.00
tenocyte, donor3	11768-123I4	27.43	7.78	6.67	2.59	1.11	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	38.58	26.85	1.19	3.40	0.00	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	6.63	2.62	0.92	1.08	0.00	0.00
teratocarcinoma cell line:PA-1	10807-111A6	27.12	12.40	1.08	2.94	0.15	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	19.68	10.92	1.65	2.92	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	19.66	10.21	0.76	2.27	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.79	32.94	2.62	7.42	0.00	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	14.33	6.19	0.65	1.95	0.00	0.65
testis, adult, pool1	10026-101D8	40.37	7.73	7.09	3.54	2.58	0.86
testis, adult, pool2	10096-102C6	69.92	13.08	11.73	3.16	1.80	0.00
thalamus - adult, donor10196	10168-103B6	34.22	6.62	7.73	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	43.60	10.31	6.72	4.69	0.31	0.31
thalamus, adult, donor10258, tech_rep1	10370-105G1	29.25	9.24	9.24	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	19.10	5.11	4.28	0.82	0.66	0.16
thalamus, newborn, donor10223	10366-105F6	21.86	9.21	4.60	1.15	1.73	0.00
throat, adult	10209-103G2	22.97	3.75	3.99	3.25	0.50	0.00
throat, fetal, donor1	10061-101H7	29.86	10.06	3.35	3.66	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	0.20	0.00	0.20	0.20	0.00	0.00
thymus, adult, pool1	10027-101D9	44.44	5.67	3.08	5.37	0.30	0.20
thymus, fetal, pool1	10043-101F7	79.80	9.77	3.01	9.04	0.42	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	16.89	6.65	3.72	1.73	0.27	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	34.36	13.69	8.24	3.21	0.56	0.28
thyroid, adult, pool1	10028-101E1	27.06	5.88	2.89	3.92	0.19	0.00
thyroid, fetal, donor1	10060-101H6	18.46	4.48	2.37	1.85	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	64.67	6.16	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	23.49	4.88	5.35	1.86	0.47	0.93
tongue, fetal, donor1	10059-101H5	18.13	7.09	1.58	2.36	0.00	0.00
tonsil, adult, pool1	10047-101G2	34.06	6.11	6.81	4.11	0.50	0.00
trachea, adult, pool1	10029-101E2	21.92	4.66	4.74	2.86	0.25	0.08
trachea, fetal, donor1	10058-101H4	25.01	5.39	5.77	6.54	0.77	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	18.78	5.67	2.48	1.77	0.71	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	16.01	7.19	2.63	1.32	0.10	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	55.00	13.01	6.89	1.72	0.47	0.47
tridermal teratoma cell line:HGRT	10694-109G1	36.15	11.42	5.71	3.81	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	11.94	2.29	2.45	2.54	0.08	0.08
umbilical cord, fetal, donor1	10057-101H3	25.04	2.09	2.09	6.26	0.00	0.00
uterus, adult, pool1	10100-102D1	57.33	6.65	4.78	6.31	0.51	0.17
uterus, fetal, donor1	10055-101H1	46.07	9.21	4.10	6.66	0.00	0.51
vagina, adult	10204-103F6	34.89	7.11	0.65	1.29	0.65	0.00
vein, adult	10191-103E2	26.30	4.82	4.16	2.63	0.22	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	26.17	5.61	1.60	0.80	0.80	0.00